**Trader consensus on “No” for a new coronavirus pandemic in 2026 reflects persistently low SARS-CoV-2 circulation and the absence of any novel coronavirus capable of triggering exponential global spread.** WHO surveillance through mid-2026 shows test positivity rates at record lows (around 1–4% globally), with only modest localized upticks and roughly 14,000 reported cases and 100 deaths in a recent 28-day window—far below prior waves. Current variants under monitoring (descendants of JN.1 and XFG lineages) have not demonstrated increased public health risk or major immune escape. The COVID-19 PHEIC ended in 2023, and the virus is now managed as an endemic respiratory pathogen with moderate global risk per official assessments. Realistic scenarios that could shift odds include emergence of a new variant with substantial immune escape and higher virulence, or a zoonotic spillover of a distinct coronavirus meeting pandemic criteria, though no such signals appear in current sentinel, genomic, or animal-reservoir data.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於是
$25,779 交易量
$25,779 交易量
是
$25,779 交易量
$25,779 交易量
The resolution source will be official announcements from the World Health Organization.
市場開放時間： Jan 6, 2026, 2:40 PM ET
The resolution source will be official announcements from the World Health Organization.
**Trader consensus on “No” for a new coronavirus pandemic in 2026 reflects persistently low SARS-CoV-2 circulation and the absence of any novel coronavirus capable of triggering exponential global spread.** WHO surveillance through mid-2026 shows test positivity rates at record lows (around 1–4% globally), with only modest localized upticks and roughly 14,000 reported cases and 100 deaths in a recent 28-day window—far below prior waves. Current variants under monitoring (descendants of JN.1 and XFG lineages) have not demonstrated increased public health risk or major immune escape. The COVID-19 PHEIC ended in 2023, and the virus is now managed as an endemic respiratory pathogen with moderate global risk per official assessments. Realistic scenarios that could shift odds include emergence of a new variant with substantial immune escape and higher virulence, or a zoonotic spillover of a distinct coronavirus meeting pandemic criteria, though no such signals appear in current sentinel, genomic, or animal-reservoir data.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions